Novozymes, Solvay Pharmaceuticals Inc. deal

Solvay obtained rights from Novozymes to a recombinant enzyme for use in pharmaceutical development. Novozymes received an upfront payment and is entitled to royalties if Solvay markets the enzyme. No...